universal health care system
Recently Published Documents


TOTAL DOCUMENTS

104
(FIVE YEARS 34)

H-INDEX

17
(FIVE YEARS 4)

2021 ◽  
pp. 219256822110469
Author(s):  
Oliver GS Ayling ◽  
Tamir Ailon ◽  
Michael Craig ◽  
Nicolas Dea ◽  
Greg McIntosh ◽  
...  

Study Design Ambispective cohort study. Objective Canada has a government-funded universal health care system. The United States utilizes a multitier public and private system. The objective is to investigate differences in clinical outcomes between those surgically treated for lumbar disc herniation in a universal health care and multitier health system. Methods Surgical lumbar disc herniation patients enrolled in the Canadian Spine Outcome Research Network (CSORN) were compared with the surgical cohort enrolled in the Spine Patients Outcome Research Trial (SPORT) study. Baseline demographics and spine-related patient-reported outcomes (PROs) were compared at 3 months and 1 year post-operatively. Results The CSORN cohort consisted of 443 patients; the SPORT cohort had 763 patients. Patients in the CSORN cohort were older (46.4 ± 13.5 vs 41.0 ± 10.8, P < .001) and were more likely to be employed (69.5% vs 60.3%, P = .003). The CSORN cohort demonstrated significantly greater rates of satisfaction after surgery at 3 months (87.2% vs 64.8%, P < .0001) and 1 year (85.6% vs 69.6%, P < .0001). Improvements in back and leg pain followed similar trajectories in the two cohorts, but there was less improvement on ODI in the CSORN cohort ( P < .01). On multivariable logistic regression, the CSORN cohort was a significant independent predictor of patient satisfaction at 1-year follow-up ( P < .001). Conclusions Despite less improvement on ODI, patients enrolled in CSORN, as part of a universal health care system, reported higher rates of satisfaction at 3 months and 1 year post-operatively compared to patients enrolled within a multitier health system.


Author(s):  
Kate Allan ◽  
Nicolette Joh-Carnella ◽  
Barbara Fallon ◽  
Ashley Vandermorris ◽  
Emmaline Houston

Abstract Objectives This study explores child welfare investigations for medical neglect in Ontario, Canada, focusing on household, family and child characteristics of such investigations and factors associated with substantiated victimization. Methods This analysis used data from the Ontario Incidence Study of Reported Child Abuse and Neglect 2018. Bivariate analyses compared medical neglect with other neglect investigations to create a profile of medical neglect investigations in Ontario, and a binary logistic regression determined which case characteristics were associated with substantiation of medical neglect. Results Compared with other neglect investigations, medical neglect investigations were more likely to involve children less than 1 year old and caregivers under 21 years old, households that had run out of money in the past 6 months for basic necessities, primary caregivers with few social supports, mental health issues or drug/solvent abuse concerns, and children with at least one functioning concern. Medical neglect investigations in which the primary caregiver had few social supports were almost four times more likely to be substantiated (OR=3.698, P&lt;0.05). Conclusions While the public’s perception of medical neglect tends to focus on parental refusal of treatment due to philosophical/religious beliefs, this Ontario sample indicates that medical neglect is often driven by financial constraints and a lack of social support. Implications for health care providers within a universal health care system are discussed.


2021 ◽  
pp. 147775092110114
Author(s):  
Marina Morla-González ◽  
Clara Moya-Guillem ◽  
David Rodríguez-Arias ◽  
Íñigo de Miguel Beriain ◽  
Alberto Molina-Pérez ◽  
...  

Organ shortage constitutes an unsolved problem for every country that offers transplantation as a therapeutic option. Besides the largely implemented donation model and the eventually implemented market model, a theorized automatic organ procurement model has raised a rich debate in the legal, medical and bioethical community, since it could show a higher potential to solve organ shortage. In this paper, we study the main arguments for and against this model. We show how, in the light of empirical data extracted from countries with a universal health care system, its implementation could lead to a positive impact on organ procurement rates. Three factors are envisioned as fundamental in the comprehension and a possible regulation of the automatic organ procurement model: the lack of recognition of the conscientious objection, the preservation of the right to choose end of life conditions, and the need to avoid incentives for families or healthcare professionals.


2021 ◽  
pp. 120347542110081
Author(s):  
Alexandra Finstad ◽  
Nouf Almuhanna ◽  
Raed Alhusayen

Background Limited data is available on the burden of dermatologic disease including disease distribution and providers of care. Research is needed to facilitate health care planning and improve patient care. Objectives To investigate the demographics and economics of the provision of dermatologic care in a universal health care system from fiscal year 2000 to 2016. Methods A retrospective population-based analysis was performed on physician billing claims for dermatologic conditions from April 1, 2000 to March 31, 2017. Data came from the province of Ontario’s universal health care plan claims records accessed through IntelliHealth. Results Dermatologic claims made up 3.6% of all physician claims, with a 20% increase seen over time. The cost of dermatologic claims increased by 70% between fiscal 2000 and 2016, with the average cost per claim increasing by 41%. However, the cost of dermatologic claims as a percentage of all health care claims experienced a decline from 3.5% in fiscal 2000 to 2.8% in fiscal 2016. Over the study period, family physicians submitted 56% to 62% of dermatologic claims, dermatologists 24% to 29%, pediatricians 3% to 4%, and internists 1%. Overall, internists billed the highest average cost per dermatologic claim ranging from $39 in 2000 to $60 in 2016, followed by pediatricians at $33 to $58, dermatologists at $28 to $39, and family physicians at $23 to $30. Conclusions The demographic and economic burden of dermatologic disease is changing over time, with implications for health care planning, advancing medical education, and patient care.


2021 ◽  
Vol 4 (3) ◽  
pp. e211104
Author(s):  
Antoine Eskander ◽  
Qing Li ◽  
Julie Hallet ◽  
Natalie Coburn ◽  
Timothy P. Hanna ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1121
Author(s):  
Chiaki Inagaki ◽  
Daichi Maeda ◽  
Kazue Hatake ◽  
Yuki Sato ◽  
Kae Hashimoto ◽  
...  

Next-generation sequencing (NGS) assay is part of routine care in Japan owing to its reimbursement by Japan’s universal health-care system; however, reimbursement is limited to patients who finished standard treatment. We retrospectively investigated 221 patients who underwent Foundation One CDX (F1CDx) at our hospital. Every F1CDx result was assessed at the molecular tumor board (MTB) for treatment recommendation. Based on patients’ preferences, presumed germline findings were also assessed at the MTB and disclosed at the clinic. In total, 204 patients underwent F1CDx and 195 patients completed the analysis; however, 13.8% of them could not receive the report due to disease progression. Among 168 patients who received the results, 41.6% had at least one actionable alteration, and 3.6% received genomically matched treatment. Presumed germline findings were nominated in 24 patients, and 16.7% of them contacted a geneticist counselor. The NGS assay should be performed earlier in the clinical course to maximize the clinical benefit. Broader reimbursement for the NGS assay would enhance the delivery of precision oncology to patients. Access to clinical trials affects the number of patients who benefit from NGS. Additionally, the disclosure of presumed germline findings is feasible in clinical practice.


2021 ◽  
Vol 6 ◽  
Author(s):  
Sarah Rudrum

Drawing on journal entries written by a cohort of pregnant Canadians, this article explores how responses to the COVID-19 pandemic shaped access to and experiences of maternity care. Variance in practices among jurisdictions and among provider groups meant that participants had diverse experiences. Nevertheless, I identify clear shared concerns, including fear over giving birth with no familial support, the need for better communications, and challenges entailed when needing to switch providers or travel for care during a state of emergency. Despite a universal health care system, there are gaps and inequities in access to appropriate maternity care in Canada; the pandemic exposed existing access challenges.


Sign in / Sign up

Export Citation Format

Share Document